| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |